Release Date: 01/11/21 07:58 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 277.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%